Dow Up 0.51% Nasdaq Up 0.24%

Geron Corporation (GERN)

-NasdaqGS
3.70 Up 0.45(13.85%) Nov 21, 4:00PM EST
|After Hours : 3.71 Up 0.01 (0.27%) Nov 21, 7:54PM EST
Prev Close:3.25
Open:3.30
Bid:N/A
Ask:3.74 x 3000
1y Target Est:4.63
Beta:2.89
Next Earnings Date:N/A
Day's Range:3.28 - 3.76
52wk Range:1.31 - 6.54
Volume:18,360,473
Avg Vol (3m):3,707,900
Market Cap:581.68M
P/E (ttm):N/A
EPS (ttm):-0.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 13.85%581.68M
BMYUp 0.32%97.54B
GSKUp 0.04%111.55B
NVSDown 0.30%229.73B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):425.78
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.12
Quarterly EPS Est (Dec-14) :0.05
Mean Recommendation*:2.5
PEG Ratio (5 yr expected):-5.42

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, develops a telomerase inhibitor, imetelstat, to treat hematologic myeloid malignancies. The company was founded in 1990 and is based in Menlo Park, California. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback